GenMark Diagnostics, Inc.·4

Jun 1, 5:19 PM ET

Mitchell Brian Andrew 4

4 · GenMark Diagnostics, Inc. · Filed Jun 1, 2020

Insider Transaction Report

Form 4
Period: 2020-05-28
Mitchell Brian Andrew
SVP, Operations
Transactions
  • Sale

    Common Stock

    2020-05-28$9.52/sh2,021$19,240238,808 total
Footnotes (2)
  • [F1]The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.
  • [F2]The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $9.48 to $9.54 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price.

Documents

1 file
  • 4
    wf-form4_159104633604891.xmlPrimary

    FORM 4